- TRPML1 is a promising target1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement in...
IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human clinical trialsBOSTON, Jan. 28,...
Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™...
Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of...
RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its...
Ad hoc announcement pursuant to Art. 53 LR Regulatory dossier to obtain marketing authorization for QUVIVIQ has been submitted to...
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market...
Successfully identified PFOs in 30 patients across the Netherlands and UKFOQUS scans the whole brain for emboli in 40 seconds...
Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS PharmaceuticalsStrategic Focus, Pipeline...
Study aims to evaluate promising therapeutics that could slow or halt progression of Parkinson’s disease in prodromal patientsATLANTA and BOSTON,...
WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer...
PURCHASE, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage...
N.I.S. New Investment Solutions leads investment in the leading provider of solar steamDUBAI, UAE, Jan. 26, 2026 /PRNewswire/ -- GlassPoint, the...
Oticon Zeal™ is the world's most discreet, complete hearing aidSOMERSET, N.J., Jan. 26, 2026 /PRNewswire/ -- HearingLife is proud to...
BURLINGTON, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the...
RICHMOND, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), today announced completion of its redomiciliation from...
HONG KONG, Jan. 26, 2026 /PRNewswire/ -- Prof. Nancy IP, President of The Hong Kong University of Science and Technology (HKUST),...
HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in...
Peer-reviewed research by Dr Joe Dispenza and HeartMath Institute reveals measurable global effects of emotionally coherent group meditationSAN DIEGO, Jan. 23,...
Peer-reviewed research by Dr Joe Dispenza and HeartMath Institute reveals measurable global effects of emotionally coherent group meditationSAN DIEGO, Jan. 23,...